• Sumitomo Pharma addressed a Gotham City Research report published Aug. 3, 2026, calling it the author’s independent views.
• Financial statements were prepared under applicable standards, audited under Japanese law, with an unqualified audit opinion.
• No facts confirmed on alleged misstatements or inappropriate accounting; no plan to revise previously disclosed financial statements as of Aug. 4, 2026.
• Commitment reiterated to timely, appropriate disclosure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sumitomo Pharma Co. Ltd. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.